Clinical Trials Browser

Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Nasopharyngeal Neoplasms, Oropharyngeal Neoplasms, Paranasal Sinus Neoplasms, Salivary Gland Neoplasms

NCT00400205 2017-11-06

Study of Induction Docetaxel, Cisplatin and 5-Fluorouracil

Phase 2 Terminated

14 enrolled 8 charts

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Mouth Neoplasms

NCT00272181 2015-12-23

Study of Proxinium for Treating Patients With Squamous Cell Head and Neck Cancer

Phase 2 Terminated

15 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Head and Neck Neoplasms, Mouth Neoplasms, Neoplasms, Squamous Cell

NCT00003223 2012-07-24

SWOG-9507, Fenretinide in Treating Patients With Neoplasia of the Mouth

Phase 2 Terminated

5 enrolled

Head & Neck

Head and Neck Neoplasms, Mouth Neoplasms

Clinical Trials

NBI-CAB

Celecoxib Through Surgery and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer

A Phase II Trial of TPF Induction Chemotherapy in cN2 OSCC Patients

A Study of CDX-3379 and Cetuximab and in Patients With Advanced Head and Neck Squamous Cell Carcinoma

ACTOplus Met XR in Treating Patients With Stage I-IV Oral Cavity or Oropharynx Cancer Undergoing Definitive Treatment

Surgery, Radiation Therapy, and Combination Chemotherapy in Treating Patients With Recurrent Head and Neck Cancer

CTXMAB+RT

Antineoplaston Therapy in Treating Patients With Advanced Head and Neck Cancer

Study of Induction Docetaxel, Cisplatin and 5-Fluorouracil

Study of Proxinium for Treating Patients With Squamous Cell Head and Neck Cancer

SWOG-9507, Fenretinide in Treating Patients With Neoplasia of the Mouth